| Literature DB >> 35758382 |
Liang-Ying Chen1, Yu-Han Hong1, Shao-Ciao Luo2,3, Jing-Tong Fu4, Sz-Iuan Shiu5,6,7,8.
Abstract
INTRODUCTION: Dieulafoy's lesion (DL) presented with small bowel bleeding constitutes a group of rare and potentially life-threatening prognosis. Several case series have described this condition, yet it remains unclear as to what is the optimal treatment and predicted outcome for patients who have been diagnosed. PATIENT CONCERNS: We present a 21-year-old male experiencing bloody stool for 1 day. DIAGNOSIS: Computed tomography of the abdomen exhibited active contrast extravasations and segmental wall thickening in the jejunum, and enteroscopy showed one 15-millimeter sized subepithelial tumor at the proximal jejunum.Entities:
Mesh:
Year: 2022 PMID: 35758382 PMCID: PMC9276124 DOI: 10.1097/MD.0000000000029474
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1Active contrast extravasations and segmental wall thickening of jejunum (arrowhead) detected by computed tomography of abdomen with biphasic contrast enhancement (A). Emergent transcatheter arterial embolization performed immediately and after angiographic confirmation of active bleeding from branch of superior mesenteric artery (B) superselective embolization completed by gelform cubes injection (arrowhead) (C). A 15 millimeters subepithelial tumor at proximal jejunum (asterisk) with ulceration centrally and hyperemia peripherally observed via double balloon enteroscopy (D). SMA: superior mesenteric artery, IMA: inferior mesenteric artery.
Figure 2A laparoscopic surgical resection showed the location of subepithelial tumor with tattoo. (A). Jejunal Dieulafoy's lesion with organizing thrombus (asterisk) (B) and nearby nutritional vessel (arrowhead) (C) confirmed by pathology.
Univariate analysis of the clinical parameters related to mortality in patients with intestinal Dieulafoy's lesion.
| Total | Univariate | |||
| Odds ratio | 95%CI | |||
| Age | 91 | |||
| <65 years of age | 56 | Reference | Reference | |
| ≥65 years of age | 35 | 4.91 | 0.19–124.02 | 0.33 |
| Gender | 90 | |||
| Women | 35 | Reference | Reference | |
| Men | 55 | 0.21 | 0.01–5.23 | 0.34 |
| Comorbidity | 54 | |||
| None | 10 | Reference | Reference | |
| Coagulopathy | 4 | 9.00 | 0.29–275.58 | 0.21 |
| Pharmacology | 87 | |||
| None | 57 | Reference | Reference | |
| Anti-platelets | 12 | – | – | – |
| Anticoagulant | 10 | 18.16 | 0.69–479.41 | 0.08 |
| Organ dysfunction | 23 | |||
| None | 2 | Reference | Reference | |
| Yes | 21 | 0.37 | 0.01–11.63 | 0.57 |
| Location | 92 | |||
| Duodenum | 34 | Reference | Reference | |
| Jejunum | 43 | 2.44 | 0.10–61.69 | 0.59 |
| Ileum | 15 | – | – | – |
| Treatment | ||||
| Endoscopy | 46 | Reference | Reference | |
| Radiology | 3 | 4.33 | 0.15–127.31 | 0.40 |
| Surgery | 42 | 0.36 | 0.01–9.00 | 0.53 |